
Sign up to save your podcasts
Or


The classification of aging as a disease is a subject of intense debate within the scientific and medical communities. Proponents argue that such a classification would accelerate the development of treatments and funding, while opponents warn of ethical consequences and the risk of pathologizing a natural process.
Arguments for Classifying Aging as a Disease Supporters, such as proponents of the Strategies for Engineered Negligible Senescence (SENS) framework, argue that aging fits the medical definition of a disease because it involves specific physiological dysfunctions (like genomic instability and cellular senescence) that lead to harmful outcomes. They contend that classifying aging as a disease would:
• Unlock Funding and Regulation: Currently, regulatory bodies like the FDA require a specific disease indication to approve drugs. Classifying aging as a disease would allow pharmaceutical companies to target the underlying causes of aging (e.g., via the TAME trial for metformin) rather than just treating its symptoms.
• Improve Healthspan: By viewing aging as a treatable condition rather than an inevitable decline, medicine could focus on preventative maintenance and repair, potentially compressing the period of morbidity (illness) at the end of life.
• Analogy to Other Conditions: Supporters point out that conditions like osteoporosis and obesity were once considered natural consequences of life or lifestyle but are now treatable diseases.
Arguments Against Classifying Aging as a Disease Opponents argue that aging is a universal, natural process, distinct from disease, which is typically defined as a deviation from normal species functioning. Arguments against the classification include:
• Risk of Ageism: Critics warn that labeling aging as a disease promotes "hallmarks of ageism," reinforcing stereotypes that older adults are "defective" or "worn out". This stigma can negatively impact the psychological well-being of older adults and lead to discrimination.
• Pathologizing Life: Biologists note that aging is an emergent property of life and evolutionary neglect, not a specific pathology. Treating it as a disease effectively pathologizes the human life course.
• Clinical Risks: Physicians express concern that a blanket diagnosis of "old age" could lead to inadequate care, where specific, treatable conditions are dismissed as mere symptoms of aging.
Current Status The World Health Organization (WHO) became a focal point of this debate with its 11th Revision of the International Classification of Diseases (ICD-11). Initially, the WHO included a code for "old age," but following significant backlash from the gerontological community, this was retracted and replaced with "ageing-associated decline in intrinsic capacity". This shift attempts to recognize the functional declines associated with aging without explicitly defining old age itself as a disease. Currently, frameworks like the "Hallmarks of Aging" focus on targeting the biological mechanisms of aging to extend healthspan without necessarily adopting the "disease" label.
By Stackx StudiosThe classification of aging as a disease is a subject of intense debate within the scientific and medical communities. Proponents argue that such a classification would accelerate the development of treatments and funding, while opponents warn of ethical consequences and the risk of pathologizing a natural process.
Arguments for Classifying Aging as a Disease Supporters, such as proponents of the Strategies for Engineered Negligible Senescence (SENS) framework, argue that aging fits the medical definition of a disease because it involves specific physiological dysfunctions (like genomic instability and cellular senescence) that lead to harmful outcomes. They contend that classifying aging as a disease would:
• Unlock Funding and Regulation: Currently, regulatory bodies like the FDA require a specific disease indication to approve drugs. Classifying aging as a disease would allow pharmaceutical companies to target the underlying causes of aging (e.g., via the TAME trial for metformin) rather than just treating its symptoms.
• Improve Healthspan: By viewing aging as a treatable condition rather than an inevitable decline, medicine could focus on preventative maintenance and repair, potentially compressing the period of morbidity (illness) at the end of life.
• Analogy to Other Conditions: Supporters point out that conditions like osteoporosis and obesity were once considered natural consequences of life or lifestyle but are now treatable diseases.
Arguments Against Classifying Aging as a Disease Opponents argue that aging is a universal, natural process, distinct from disease, which is typically defined as a deviation from normal species functioning. Arguments against the classification include:
• Risk of Ageism: Critics warn that labeling aging as a disease promotes "hallmarks of ageism," reinforcing stereotypes that older adults are "defective" or "worn out". This stigma can negatively impact the psychological well-being of older adults and lead to discrimination.
• Pathologizing Life: Biologists note that aging is an emergent property of life and evolutionary neglect, not a specific pathology. Treating it as a disease effectively pathologizes the human life course.
• Clinical Risks: Physicians express concern that a blanket diagnosis of "old age" could lead to inadequate care, where specific, treatable conditions are dismissed as mere symptoms of aging.
Current Status The World Health Organization (WHO) became a focal point of this debate with its 11th Revision of the International Classification of Diseases (ICD-11). Initially, the WHO included a code for "old age," but following significant backlash from the gerontological community, this was retracted and replaced with "ageing-associated decline in intrinsic capacity". This shift attempts to recognize the functional declines associated with aging without explicitly defining old age itself as a disease. Currently, frameworks like the "Hallmarks of Aging" focus on targeting the biological mechanisms of aging to extend healthspan without necessarily adopting the "disease" label.